Patent 9353165 was granted and assigned to Grifols on May, 2016 by the United States Patent and Trademark Office.
Described herein are methods for purifying recombinant, cell culture derived alpha1-protease inhibitor and removing a colored species that co-purifies with the recA1PI protein. Also described are methods for reducing the iron in cell culture derived alpha1-protease inhibitor.